377 related articles for article (PubMed ID: 25218275)
1. Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus.
Wang YT; Huang HY; Tsai MA; Wang PC; Jiang BH; Chen SC
Fish Shellfish Immunol; 2014 Dec; 41(2):250-9. PubMed ID: 25218275
[TBL] [Abstract][Full Text] [Related]
2. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
Zhang Z; Yu A; Lan J; Zhang H; Hu M; Cheng J; Zhao L; Lin L; Wei S
Fish Shellfish Immunol; 2017 Apr; 63():255-260. PubMed ID: 28219739
[TBL] [Abstract][Full Text] [Related]
3. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination.
Pasnik DJ; Evans JJ; Klesius PH
Dis Aquat Organ; 2005 Sep; 66(2):129-34. PubMed ID: 16231638
[TBL] [Abstract][Full Text] [Related]
4. Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
Nur-Nazifah M; Sabri MY; Siti-Zahrah A
Fish Shellfish Immunol; 2014 Mar; 37(1):193-200. PubMed ID: 24486904
[TBL] [Abstract][Full Text] [Related]
5. GroEL, a novel vaccine candidate of piscine Streptococcus agalactiae identified by immunoproteome.
Li W; Li Y; Hu YZ; Mo XB; Xu GH; Xie LW; Li AX
Fish Shellfish Immunol; 2019 Jan; 84():377-383. PubMed ID: 30308296
[TBL] [Abstract][Full Text] [Related]
6. Passive immunization of Nile tilapia (Oreochromis niloticus) provides significant protection against Streptococcus agalactiae.
Pasnik DJ; Evans JJ; Klesius PH
Fish Shellfish Immunol; 2006 Oct; 21(4):365-71. PubMed ID: 16531069
[TBL] [Abstract][Full Text] [Related]
7. Generation of a novel Streptococcus agalactiae ghost vaccine and examination of its immunogenicity against virulent challenge in tilapia.
Wang Q; Wang X; Wang X; Feng R; Luo Q; Huang J
Fish Shellfish Immunol; 2018 Oct; 81():49-56. PubMed ID: 29969706
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
Evans JJ; Klesius PH; Shoemaker CA
Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
[TBL] [Abstract][Full Text] [Related]
9. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity of Streptococcus agalactiae extracellular products and vaccine efficacy.
Pasnik DJ; Evans JJ; Panangala VS; Klesius PH; Shelby RA; Shoemaker CA
J Fish Dis; 2005 Apr; 28(4):205-12. PubMed ID: 15813862
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive evaluation of immunomodulation by moderate hypoxia in S. agalactiae vaccinated Nile tilapia.
Gallage S; Katagiri T; Endo M; Maita M
Fish Shellfish Immunol; 2017 Jul; 66():445-454. PubMed ID: 28526572
[TBL] [Abstract][Full Text] [Related]
12. Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus).
Wong KY; Megat Mazhar Khair MH; Song AAL; Masarudin MJ; Loh JY; Chong CM; Beardall J; Teo MYM; In LLA
Fish Shellfish Immunol; 2024 Jun; 149():109572. PubMed ID: 38636739
[TBL] [Abstract][Full Text] [Related]
13. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia.
Ma YP; Ke H; Liang ZL; Ma JY; Hao L; Liu ZX
Fish Shellfish Immunol; 2017 Jul; 66():345-353. PubMed ID: 28476676
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
[TBL] [Abstract][Full Text] [Related]
16. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture.
Liu L; Lu DQ; Xu J; Luo HL; Li AX
J Fish Dis; 2019 May; 42(5):693-701. PubMed ID: 30893488
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory responses of Nile tilapia Oreochromis niloticus to Streptococcus agalactiae: effects of vaccination and yeast diet supplement.
Salvador R; Toazza CS; de Moraes JR; de Moraes FR
Dis Aquat Organ; 2012 Apr; 98(3):235-41. PubMed ID: 22535873
[TBL] [Abstract][Full Text] [Related]
18. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro.
Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X
Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276
[TBL] [Abstract][Full Text] [Related]
19. The effect of intermittent hypoxia under different temperature on the immunomodulation in Streptococcus agalactiae vaccinated Nile tilapia (Oreochromis niloticus).
Wang J; Lu DQ; Jiang B; Luo HL; Lu GL; Li AX
Fish Shellfish Immunol; 2018 Aug; 79():181-192. PubMed ID: 29684601
[TBL] [Abstract][Full Text] [Related]
20. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
Pridgeon JW; Klesius PH
Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
